ORIGINAL RESEARCH
Published on 24 Dec 2024
Optimized BCMA/CS1 bispecific TRuC-T cells secreting IL-7 and CCL21 robustly control multiple myeloma
doi 10.3389/fimmu.2024.1502936
- 1,869 views
- Frontiers in Hematology
- Blood Cancer
- Research Topics
- Understanding Complications and Outcomes of Anti-BCMA Treatments in Relapsed Multiple Myeloma
Understanding Complications and Outcomes of Anti-BCMA Treatments in Relapsed Multiple Myeloma
1,834
Total downloads
6,868
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: